Moderna, Inc. (MRNA) vs Regeneron Pharmaceuticals, Inc. (REGN)

• Moderna, Inc. MRNA 218.01 ▼ −7.82%
• Regeneron Pharmaceuticals, Inc. REGN 790.74 ▼ −0.70%

Moderna, Inc. and Regeneron Pharmaceuticals, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $94.4B against $82.0B — 1.2× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 18.9×. Regeneron Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 9.29% against −27.6%. Regeneron Pharmaceuticals, Inc. has the higher net margin (27.9% vs −141.4%) and the higher return on invested capital (9.34% vs −93.5%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 17 and Moderna, Inc. on 2.